Income tax benefit (d) (12)
Restructuring-related charges, net of tax $32
Amortization expense $143 $155
Income tax benefit (d) (34) (33)
Amortization expense, net of tax $109 $122
(a) Recorded expenses of $9 million to selling, general and administrative
expenses, $2 million to cost of products sold, and $1 million to
research and development expenses.
(b) Recorded to other, net.
(c) Recorded $29 million to restructuring charges, $9 million to selling,
general and administrative expenses, $4 million to cost of products
sold, and $2 million to research and development expenses.
(d) Amounts are tax effected at the Company's effective tax rate, unless
the amount is a significant unusual or infrequently occurring item in
accordance with FASB Interpretation No. 18, "Accounting for Income
Taxes in Interim Periods."
BOSTON SCIENTIFIC CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
March 31, December 31,
In millions 2008 2007
Cash and cash equivalents $1,739 $1,452
Trade accounts receivable, net 1,496 1,502
Inventories 781 725
Deferred income taxes 873 679
Assets held for sale 1,099
Other current assets 352
|SOURCE Boston Scientific Corporation|
Copyright©2008 PR Newswire.
All rights reserved